Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
Learn more: Charité researchers lay the groundwork for drugs with fewer side effects
The Latest on: Pain medications
[google_news title=”” keyword=”pain medications” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pain medications
- 11 Causes of Pain on the Outer Side of Your Footon April 27, 2024 at 3:54 am
Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to treat it.
- A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemicon April 26, 2024 at 2:20 pm
Studies found that Chronic pain is more prevalent and costly than cancer, diabetes, and heart disease combined, and its rates are rising even as other chronic ...
- Scientists Make Breakthrough in Chronic Pain Treatmenton April 26, 2024 at 7:53 am
Scientists have developed tiny robotic nerve "cuffs" to diagnose and treat neurological disorders. The flexible devices offer a safer, minimally invasive alternative to today's diagnostics and could ...
- The Brain Reacts to Racism by Experiencing Painon April 25, 2024 at 11:59 am
Neurobiological research shows the pain infused reaction brains have to racism. Racism's repeated blows to neurobiology come from individuals, employers, culture, politics, and society. Chronic pain ...
- Painful Truth Campaign encourages non-opioid solutions for pain reliefon April 25, 2024 at 11:21 am
The United States makes up around 4% of the world's population, but it consumes more than 80% of the world's opioids.
- Three-quarters of New Jerseyans Familiar With Proper Guidelines to Store and Dispose of Medications, Opioids and Edibleson April 25, 2024 at 6:37 am
Forty-two percent of residents polled in December say they are very familiar with the proper guidelines to store and dispose of any form of medication, opioids and/or edibles in a household, 32 ...
- Here's what to do with old prescriptions, medicationson April 24, 2024 at 9:59 pm
The state of Texas will hold a prescription take-back day, a nationally recognized event, April 27, offering individuals a safe, convenient way to dispose of unused prescription drugs, as well as ...
- Have You Ever Taken Too Much of Your Rescue Medication?on April 24, 2024 at 8:47 am
Rebound headaches, often called "medication overuse headaches," can affect chronic migraine sufferers. The only way to stop them is to totally remove the rescue drugs we typically turn to when really ...
- A Close Look at Denial of Pain Meds to People Who Use Drugson April 18, 2024 at 7:05 am
Researchers investigated factors associated with denial. These included self-management of pain prior to seeking formal pain treatment.
via Bing News